JRCT ID: jRCT2080220190
Registered date:19/12/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Patients with Crohn's disease in remission phase |
Date of first enrollment | 19/12/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Z-206 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Recurrence rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | Patients with Crohn's disease in remission phase who are defined to show CDAI of less than 150, and whose lesion is mainly observed at the end of ileum or lower part. |
Exclude criteria |
Related Information
Primary Sponsor | Zeria Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050193 |
Contact
Public contact | |
Name | |
Address | kaihatu@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |